Mannose metabolism normalizes gut homeostasis by blocking the TNF-α-mediated proinflammatory circuit

[1]  A. Ouwehand,et al.  Role of D-mannose in urinary tract infections – a narrative review , 2022, Nutrition Journal.

[2]  E. Perlstein,et al.  Sorbitol Is a Severity Biomarker for PMM2‐CDG with Therapeutic Implications , 2021, Annals of neurology.

[3]  Amy S. Shah,et al.  PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver disease. , 2021, Cell metabolism.

[4]  A. Kajaste-Rudnitski,et al.  D-mannose suppresses macrophage IL-1β production , 2020, Nature Communications.

[5]  Jamma Trinath,et al.  Endoplasmic Reticulum Stress and Intestinal Inflammation: A Perilous Union , 2020, Frontiers in Immunology.

[6]  Graham M Lord,et al.  Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional programme in colonic epithelial cells , 2019, Gut.

[7]  G. Matteoli,et al.  Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD , 2019, Nature Reviews Gastroenterology & Hepatology.

[8]  Joerg M. Buescher,et al.  Inflammatory macrophage dependence on NAD+ salvage is a consequence of reactive oxygen species–mediated DNA damage , 2019, Nature Immunology.

[9]  A. Nadin,et al.  Malonylation of GAPDH is an inflammatory signal in macrophages , 2019, Nature Communications.

[10]  Hongqiang Cheng,et al.  Phosphatase Shp2 exacerbates intestinal inflammation by disrupting macrophage responsiveness to interleukin-10 , 2019, The Journal of experimental medicine.

[11]  E. Perlstein,et al.  Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG , 2019, Disease Models & Mechanisms.

[12]  I. McNeish,et al.  Mannose impairs tumour growth and enhances chemotherapy , 2018, Nature.

[13]  S. Peterson,et al.  Mannose Alters Gut Microbiome, Prevents Diet-Induced Obesity, and Improves Host Metabolism. , 2018, Cell reports.

[14]  R. Swanson,et al.  Bioenergetic state regulates innate inflammatory responses through the transcriptional co-repressor CtBP , 2017, Nature Communications.

[15]  M. Gorospe,et al.  Polysome Fractionation to Analyze mRNA Distribution Profiles. , 2017, Bio-protocol.

[16]  L. Mcphail,et al.  GAPDH Binding to TNF-α mRNA Contributes to Posttranscriptional Repression in Monocytes: A Novel Mechanism of Communication between Inflammation and Metabolism , 2016, The Journal of Immunology.

[17]  S. Calatayud,et al.  The activation of Wnt signaling by a STAT6-dependent macrophage phenotype promotes mucosal repair in murine IBD , 2015, Mucosal Immunology.

[18]  H. Freeze,et al.  Mannose metabolism: more than meets the eye. , 2014, Biochemical and biophysical research communications.

[19]  M. Leist,et al.  Ex vivo culture of intestinal crypt organoids as a model system for assessing cell death induction in intestinal epithelial cells and enteropathy , 2014, Cell Death and Disease.

[20]  H. Freeze,et al.  The Metabolic Origins of Mannose in Glycoproteins*♦ , 2014, The Journal of Biological Chemistry.

[21]  R. Kaufman,et al.  The unfolded protein response and chemical chaperones reduce protein misfolding and colitis in mice. , 2013, Gastroenterology.

[22]  H. Clevers,et al.  ER stress causes rapid loss of intestinal epithelial stemness through activation of the unfolded protein response. , 2013, Cell reports.

[23]  Michael Hagemann-Jensen,et al.  2-Deoxy d-Glucose Prevents Cell Surface Expression of NKG2D Ligands through Inhibition of N-Linked Glycosylation , 2012, The Journal of Immunology.

[24]  G. Kaul,et al.  Eukaryotic elongation factor‐2 (eEF2): its regulation and peptide chain elongation , 2011, Cell biochemistry and function.

[25]  H. Freeze.  Towards a therapy for phosphomannomutase 2 deficiency, the defect in CDG-Ia patients. , 2009, Biochimica et biophysica acta.

[26]  T. Sweeting,et al.  Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease , 2009, The Journal of experimental medicine.

[27]  A. Kaser,et al.  Endoplasmic reticulum stress in the intestinal epithelium and inflammatory bowel disease. , 2009, Seminars in immunology.

[28]  M. A. Ramirez,et al.  Epalrestat: An Aldose Reductase Inhibitor for the Treatment of Diabetic Neuropathy , 2008, Pharmacotherapy.

[29]  A. Gingras,et al.  eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. , 1999, Annual review of biochemistry.

[30]  N. Hotta,et al.  Clinical investigation of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy in Japan: multicenter study. Diabetic Neuropathy Study Group in Japan. , 1996, Journal of diabetes and its complications.